These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37357981)

  • 1. Biomarkers for predicting disease course in Sanfilippo syndrome: An urgent unmet need in childhood-onset dementia.
    Winner LK; Rogers ML; Snel MF; Hemsley KM
    J Neurochem; 2023 Aug; 166(3):481-496. PubMed ID: 37357981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the eye a window to the brain in Sanfilippo syndrome?
    Beard H; Chidlow G; Neumann D; Nazri N; Douglass M; Trim PJ; Snel MF; Casson RJ; Hemsley KM
    Acta Neuropathol Commun; 2020 Nov; 8(1):194. PubMed ID: 33203474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of biomarkers for Sanfilippo syndrome.
    Saville JT; Flanigan KM; Truxal KV; McBride KL; Fuller M
    Mol Genet Metab; 2019; 128(1-2):68-74. PubMed ID: 31104888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of Sanfilippo syndrome in Spain.
    Delgadillo V; O'Callaghan Mdel M; Gort L; Coll MJ; Pineda M
    Orphanet J Rare Dis; 2013 Dec; 8():189. PubMed ID: 24314109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucopolysaccharidosis III in Mainland China: natural history, clinical and molecular characteristics of 34 patients.
    Kong W; Meng Y; Zou L; Yang G; Wang J; Shi X
    J Pediatr Endocrinol Metab; 2020 May; 33(6):793-802. PubMed ID: 32447333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive, non-invasive imaging of neurodegeneration, and prevention of it with gene replacement, in mice with Sanfilippo syndrome.
    Hemsley KM; Beard H; Chidlow G; Mammone T; Winner LK; Neumann D; King B; Snel MF; Trim PJ; Casson RJ
    Exp Neurol; 2024 Jan; 371():114610. PubMed ID: 37944880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal MRI brain volume changes over one year in children with mucopolysaccharidosis types IIIA and IIIB.
    Abreu NJ; Selvaraj B; Truxal KV; Moore-Clingenpeel M; Zumberge NA; McNally KA; McBride KL; Ho ML; Flanigan KM
    Mol Genet Metab; 2021 Jun; 133(2):193-200. PubMed ID: 33962822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome).
    Barone R; Nigro F; Triulzi F; Musumeci S; Fiumara A; Pavone L
    Neuropediatrics; 1999 Oct; 30(5):270-4. PubMed ID: 10598840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying behaviors of children with Sanfilippo syndrome: the Sanfilippo Behavior Rating Scale.
    Shapiro EG; Nestrasil I; Ahmed A; Wey A; Rudser KR; Delaney KA; Rumsey RK; Haslett PA; Whitley CB; Potegal M
    Mol Genet Metab; 2015 Apr; 114(4):594-8. PubMed ID: 25770355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observational Prospective Natural History of Patients with Sanfilippo Syndrome Type B.
    Whitley CB; Cleary M; Eugen Mengel K; Harmatz P; Shapiro E; Nestrasil I; Haslett P; Whiteman D; Alexanderian D
    J Pediatr; 2018 Jun; 197():198-206.e2. PubMed ID: 29661560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sanfilippo syndrome: a mini-review.
    Valstar MJ; Ruijter GJ; van Diggelen OP; Poorthuis BJ; Wijburg FA
    J Inherit Metab Dis; 2008 Apr; 31(2):240-52. PubMed ID: 18392742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucopolysaccharidosis type III (Sanfilippo disease) in Sweden: clinical presentation of 22 children diagnosed during a 30-year period.
    Malm G; Månsson JE
    Acta Paediatr; 2010 Aug; 99(8):1253-7. PubMed ID: 20337777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality in patients with Sanfilippo syndrome.
    Lavery C; Hendriksz CJ; Jones SA
    Orphanet J Rare Dis; 2017 Oct; 12(1):168. PubMed ID: 29061114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel conditional Sgsh knockout mouse model recapitulates phenotypic and neuropathic deficits of Sanfilippo syndrome.
    Lau AA; King BM; Thorsen CL; Hassiotis S; Beard H; Trim PJ; Whyte LS; Tamang SJ; Duplock SK; Snel MF; Hopwood JJ; Hemsley KM
    J Inherit Metab Dis; 2017 Sep; 40(5):715-724. PubMed ID: 28451919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperactivity, unexplained speech delay, and coarse facies--is it Sanfilippo syndrome?
    Saini AG; Singhi P; Sahu JK; Ganesan SL; Vyas S; Rao S; Sachdeva MU
    J Child Neurol; 2014 Aug; 29(8):NP9-12. PubMed ID: 23761035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sanfilippo syndrome: causes, consequences, and treatments.
    Fedele AO
    Appl Clin Genet; 2015; 8():269-81. PubMed ID: 26648750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The laboratory diagnosis of mucopolysaccharidosis III (Sanfilippo syndrome): A changing landscape.
    Bodamer OA; Giugliani R; Wood T
    Mol Genet Metab; 2014; 113(1-2):34-41. PubMed ID: 25127543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A).
    Meyer A; Kossow K; Gal A; Mühlhausen C; Ullrich K; Braulke T; Muschol N
    Pediatrics; 2007 Nov; 120(5):e1255-61. PubMed ID: 17938166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of early markers of disease in the mouse model of mucopolysaccharidosis IIIB.
    McCullough KB; Titus A; Reardon K; Conyers S; Dougherty JD; Ge X; Garbow JR; Dickson P; Yuede CM; Maloney SE
    J Neurodev Disord; 2024 Apr; 16(1):16. PubMed ID: 38632525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.